Feron Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 01-07-2024
- Paid Up Capital ₹ 2.72 Cr
as on 01-07-2024
- Company Age 18 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 Cr
as on 01-07-2024
- Satisfied Charges ₹ 1.25 Cr
as on 01-07-2024
- Revenue -98.75%
(FY 2021)
- Profit -1700.85%
(FY 2021)
- Ebitda 99.53%
(FY 2021)
- Net Worth -213.03%
(FY 2021)
- Total Assets -92.93%
(FY 2021)
About Feron Life Sciences
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 2.72 Cr.
The company currently has active open charges totaling ₹4.00 Cr. The company has closed loans amounting to ₹1.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bhagwan Bhardwaj and Manish Basia serve as directors at the Company.
- CIN/LLPIN
U24232DL2005PTC143658
- Company No.
143658
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Dec 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Feron Life Sciences Private Limited offer?
Feron Life Sciences Private Limited offers a wide range of products and services, including Decorative Light, Lamp & Lamp Shades, Lamps, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Catheter, Hemodialysis Catheter, Infusion Syringes & Supplies, Urological & Obstetrics Instruments, Urinary Catheter.
Who are the key members and board of directors at Feron Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhagwan Bhardwaj  | Director | 18-Jul-2020 | Current |
| Manish Basia | Director | 18-Jul-2020 | Current |
Financial Performance and Corporate Structure Insights of Feron Life Sciences.
Feron Life Sciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 98.75% decrease. The company also saw a substantial fall in profitability, with a 1700.85% decrease in profit. The company's net worth observed a substantial decline by a decrease of 213.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Feron Life Sciences?
In 2019, Feron Life Sciences had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 09 Sep 2013 | ₹4.00 Cr | Open |
The Bank Of Rajasthan Limited Creation Date: 28 Oct 2006 | ₹1.25 Cr | Satisfied |
How Many Employees Work at Feron Life Sciences?
Feron Life Sciences has a workforce of 1 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Feron Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Feron Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
